QA: Aravive Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2020_Aravive_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001513818, Aravive Inc

  xvar xval
0 AssetsCurrent 68,213,000
1 IntangibleAssetsNetIncludingGoodwill 219,000
2 PropertyPlantAndEquipmentNet 1,808,000
3 remainder_Assets 11,881,000
4 LiabilitiesCurrent 4,968,000
5 LiabilitiesNoncurrent 7,840,000
6 remainder_Liabilities 264,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense -2,519,238
9 ResearchAndDevelopmentExpense -18,838,236
10 remainder_Expenses 2,381,992
11 remainder_Revenues 3,508,763
12 remainder_NetIncome 2,890,612
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 82,121,000
1 Liabilities 13,072,000
2 Expenses -18,975,482
3 Revenues 3,508,763
4 StockholdersEquity 69,049,000
5 NetIncome 25,374,857
6 ComprehensiveNetIncome 25,374,857
7 BaseVar 60,283,928
8 EconomicCapitalRatiobeforeLimitedLiability 3.70
9 EconomicCapitalRatio 4.17

Edgar->Model Mapping

Feature Distribution

Change over Time